BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 9536388)

  • 1. Cold-induced coronary Raynaud's phenomenon in patients with systemic sclerosis.
    Lekakis J; Mavrikakis M; Emmanuel M; Prassopoulos V; Papazoglou S; Papamichael C; Moulopoulou D; Kostamis P; Stamatelopoulos S; Moulopoulos S
    Clin Exp Rheumatol; 1998; 16(2):135-40. PubMed ID: 9536388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute estrogen administration can reverse cold-induced coronary Raynaud's phenomenon in systemic sclerosis.
    Lekakis J; Mavrikakis M; Emmanuel M; Prassopoulos V; Papamichael C; Moulopoulou D; Ziaga A; Kostamis P; Moulopoulos S
    Clin Exp Rheumatol; 1996; 14(4):421-4. PubMed ID: 8871843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of cold provocation in patients with Raynaud's phenomenon.
    Wigley FM; Malamet R; Wise RA
    J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of cold challenge responses in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis.
    O'Reilly D; Taylor L; el-Hadidy K; Jayson MI
    Ann Rheum Dis; 1992 Nov; 51(11):1193-6. PubMed ID: 1466594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible myocardial perfusion defects during cold challenge in scleroderma.
    Long A; Duffy G; Bresnihan B
    Br J Rheumatol; 1986 May; 25(2):158-61. PubMed ID: 3708232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the cold pressor test on diffusing capacity. Comparison of normal subjects and those with Raynaud's disease and progressive systemic sclerosis.
    Miller MJ
    Chest; 1983 Sep; 84(3):264-6. PubMed ID: 6884100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term effect of cold provocation on single-breath carbon monoxide diffusing capacity in subjects with and without Raynaud's phenomenon.
    Gastaud M; Dolisi C; Bermon S; Gaudin P; Defauw G; Ardisson JL
    Clin Exp Rheumatol; 1995; 13(5):617-21. PubMed ID: 8575140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raynaud's phenomenon in systemic lupus erythematosus.
    Lavras Costallat LT; Valente Coimbra AM
    Rev Rhum Engl Ed; 1995 May; 62(5):349-53. PubMed ID: 7655867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cold exposure on diffusing capacity in patients with Raynaud's phenomenon.
    Wise RA; Wigley F; Newball HH; Stevens MB
    Chest; 1982 Jun; 81(6):695-8. PubMed ID: 7075304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
    Hostein J; Bost R; Carpentier P; Franco A; Fournet J
    Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in regional cerebral blood flow after a cold hand test in systemic lupus erythematosus patients with Raynaud's syndrome.
    Ferraccioli G; Di Poi E; Di Gregorio F; Giacomuzzi F; Guerra U
    Lancet; 1999 Dec 18-25; 354(9196):2135-6. PubMed ID: 10609825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker.
    Rupp PA; Mellinger S; Kohler J; Dorsey JK; Furst DE
    J Rheumatol; 1987 Aug; 14(4):745-50. PubMed ID: 3312603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cold and emotional stress in Raynaud's disease and scleroderma.
    Freedman RR; Ianni P
    Br Med J (Clin Res Ed); 1983 Nov; 287(6404):1499-502. PubMed ID: 6416474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular function at rest and during Raynaud's phenomenon in patients with scleroderma.
    Siegel RJ; O'Connor B; Mena I; Criley JM
    Am Heart J; 1984 Dec; 108(6):1469-76. PubMed ID: 6507243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of biofeedback training in treatment of Raynaud's disease and phenomenon.
    Yocum DE; Hodes R; Sundstrom WR; Cleeland CS
    J Rheumatol; 1985 Feb; 12(1):90-3. PubMed ID: 3981523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
    Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H
    Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemodynamic response of the digital artery to heat and cold in normal subjects, in systemic scleroderma and in Raynaud's disease].
    Vayssairat M; Mathieu JF; Housset E
    J Mal Vasc; 1984; 9(1):7-10. PubMed ID: 6707534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac Raynaud's phenomenon induced by cold provocation as a predictor of long-term left ventricular dysfunction and remodelling in systemic sclerosis: 7-year follow-up study.
    Mizuno R; Fujimoto S; Saito Y; Nakamura S
    Eur J Heart Fail; 2010 Mar; 12(3):268-75. PubMed ID: 20071354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient myocardial perfusion abnormalities during cold provocation test in patients with arterial hyperreactivity.
    Stefenelli T; Sochor H; Slama B; Czernin J; Pachinger O; Probst P
    Z Kardiol; 1991 Oct; 80(10):622-6. PubMed ID: 1771961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
    Wigley FM; Seibold JR; Wise RA; McCloskey DA; Dole WP
    J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.